The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1492
April 11, 2016
View Complete Issue         Table of Contents 2019 
Which Oral Anticoagulant for Atrial Fibrillation?
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Which Oral Anticoagulant for Atrial Fibrillation?
April 11, 2016 (Issue: 1492)
Direct-to-consumer advertisements continue to urge patients who take warfarin (Coumadin, and others) for atrial fibrillation to ask their doctors about the benefits of one or another of the newer oral anticoagulants.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Which Oral Anticoagulant for Atrial Fibrillation?
Article code: 1492a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.